GA

Geneva Advisors Portfolio holdings

AUM $5.81B Turnover 22.5%
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.6B
AUM Growth
+$69.6M
Cap. Flow
+$51.5M
Cap. Flow %
0.92%
Top 10 Hldgs %
21.06%
Holding
781
New
66
Increased
297
Reduced
239
Closed
62
Avg Time Held
1.3 years
Top 10 Avg Time Held
0.7 years
Top 20 Avg Time Held
0.8 years

Top Buys

Rank Stock Value
1
AMTD icon
TD Ameritrade Holding Corp
AMTD
+$41.7M
2
LYB icon
LyondellBasell Industries
LYB
+$33.9M
3
BN icon
Brookfield
BN
+$27.6M
4
CONE
CyrusOne Inc Common Stock
CONE
+$21.4M
5
BDX icon
Becton Dickinson
BDX
+$20.6M

Top Sells

Rank Stock Value
1
PII icon
Polaris
PII
+$36M
2
TROW icon
T. Rowe Price
TROW
+$31.5M
3
ELV icon
Elevance Health
ELV
+$27.8M
4
ITC
ITC HOLDINGS CORP
ITC
+$26.5M
5
AMAT icon
Applied Materials
AMAT
+$24.6M

Sector Composition

Rank Sector Weight
1 Healthcare 19.08%
2 Financials 18.2%
3 Consumer Discretionary 11.88%
4 Technology 11.08%
5 Industrials 10.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
KMI icon
151
Kinder Morgan
KMI
$74.3B
$3.49M 0.06%
90,817
+1,838
+2% +$76.7K
2014 Q4
2 quarters
NVO icon
152
Novo Nordisk
NVO
$168B
$3.46M 0.06%
126,370
-34,156
-21% -$960K
2014 Q2
4 quarters
T icon
153
AT&T
T
$158B
$3.42M 0.06%
127,431
-5,146
-4% -$133K
2013 Q2
8 quarters
CVX icon
154
Chevron
CVX
$436B
$3.4M 0.06%
35,197
+3,385
+11% +$355K
2013 Q2
8 quarters
EEM icon
155
iShares MSCI Emerging Markets ETF
EEM
$29.8B
$3.35M 0.06%
84,452
+3,059
+4% +$128K
2013 Q2
8 quarters
AMTX icon
156
Aemetis
AMTX
$103M
$3.34M 0.06%
927,105
+84,937
+10% +$371K
2014 Q2
4 quarters
TYG icon
157
Tortoise Energy Infrastructure Corp
TYG
$989M
$3.33M 0.06%
22,540
-853
-4% -$143K
2013 Q4
6 quarters
TROW icon
158
T. Rowe Price
TROW
$21.3B
$3.31M 0.06%
42,637
-390,269
-90% -$31.5M
2013 Q2
8 quarters
TRIB
159
Trinity Biotech
TRIB
$5.37M
$3.25M 0.06%
1,201
+168
+16% +$436K
2013 Q2
8 quarters
DD icon
160
DELISTED
Du Pont De Nemours E I
DD
$3.24M 0.06%
53,306
-127
-0.2% -$8.55K
2013 Q2
8 quarters
ACN icon
161
Accenture
ACN
$132B
$3.09M 0.06%
31,950
+36
+0.1% +$3.44K
2013 Q2
8 quarters
PM icon
162
Philip Morris
PM
$320B
$3.09M 0.06%
38,551
+1,691
+5% +$139K
2013 Q2
8 quarters
FNGN
163
DELISTED
Financial Engines, Inc.
FNGN
$3.08M 0.06%
72,415
+6,402
+10% +$272K
2013 Q2
8 quarters
LOPE icon
164
Grand Canyon Education
LOPE
$4.18B
$3.07M 0.05%
72,420
+14,893
+26% +$645K
2013 Q2
8 quarters
TM icon
165
Toyota
TM
$222B
$3.07M 0.05%
22,963
+1,557
+7% +$215K
2014 Q4
2 quarters
ESRX
166
DELISTED
Express Scripts Holding Company
ESRX
$3.03M 0.05%
34,048
+3,177
+10% +$278K
2013 Q2
8 quarters
GLD icon
167
SPDR Gold Trust
GLD
$139B
$3.01M 0.05%
26,796
-1,077
-4% -$123K
2013 Q2
8 quarters
SIG icon
168
Signet Jewelers
SIG
$4.14B
$2.97M 0.05%
23,169
-3,831
-14% -$513K
2013 Q2
8 quarters
TTM
169
DELISTED
Tata Motors Limited
TTM
$2.96M 0.05%
85,993
-716
-0.8% -$28.5K
2014 Q1
5 quarters
PSXP
170
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
$2.91M 0.05%
40,475
+2,220
+6% +$160K
2014 Q1
5 quarters
NGLS
171
DELISTED
TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT
NGLS
$2.9M 0.05%
75,131
-982
-1% -$42.5K
2013 Q2
8 quarters
BAX icon
172
Baxter International
BAX
$12.8B
$2.83M 0.05%
74,566
+120
+0.2% +$4.49K
2013 Q2
8 quarters
NVS icon
173
Novartis
NVS
$279B
$2.77M 0.05%
31,478
+3,326
+12% +$305K
2013 Q2
8 quarters
ORCL icon
174
Oracle
ORCL
$396B
$2.73M 0.05%
67,798
+5,853
+9% +$254K
2013 Q2
8 quarters
HON icon
175
Honeywell
HON
$65.8B
$2.73M 0.05%
29,802
+20
+0.1% +$1.86K
2013 Q2
8 quarters
5 6
7
8 9

Similar funds

CAM
Capstone Asset Management Houston, Texas $3.6B AUM 20.22% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
RBC
Ronald Blue & Co Roswell, Georgia $3.1B AUM 12.82% 1-Year Est. Return
TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
HCM
Holland Capital Management Chicago, Illinois $2.28B AUM 23.08% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return

Geneva Advisors's Q2 2015 Portfolio in Review

As of Q2 2015, Geneva Advisors held 781 positions worth $5.6B, up 1.3% from $5.53B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Geneva Advisors's Q2 2015 filing shows 66 new, 297 increased, 239 reduced and 62 closed positions. Its largest new stake was LinkedIn Corporation: 75,249 shares worth $15.5M. The largest sale was Polaris, an estimated $36M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Geneva Advisors's largest Q2 2015 buy was LinkedIn Corporation: 75,249 shares worth $15.5M.
  • Geneva Advisors added most to TD Ameritrade Holding Corp in Q2 2015, an estimated $41.7M increase.
  • Geneva Advisors's biggest Q2 2015 reduction was Polaris, cutting an estimated $36M.
  • Geneva Advisors fully exited Applied Materials in Q2 2015, selling an estimated $24.6M.
  • Geneva Advisors's ten largest holdings make up 21% of its $5.6B portfolio in Q2 2015.
  • Geneva Advisors opened 66 new positions and closed 62 in Q2 2015.
  • Geneva Advisors's portfolio value rose 1.3% quarter-over-quarter to $5.6B.

Based on Geneva Advisors's 13F filing for Q2 2015, filed 3 Aug 2015.